Evidence-based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine
- MeSH Terms
- Medication Adherence (F01.145.488.500.500); Prescriptions (N02.421.668.778); Dementia (C10.228.140.380)
- Guideline Contact
- University of Sydney (Australia), Bruyère Research Institute (Canada) (guideline authors)
- Publication Scope
- management
- rehabilitation
- treatment
- Countries of Application
- Australia
- Canada
- Guideline Publication Status
- Published
- Languages
- English
- Publication Year
- 2018
- Name of Endorsing Organization
- NHMRC (AU)